论文部分内容阅读
1 文献来源rnAttar EC,Johnson JL,Amrein PC,et al.Bortezomib added to Daunorubicin and Cytarabine during induction therapy and to intermediate-dose Cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60to 75 years:CALGB (Alliance) study 10502 [J].J Clin Oncol,2013,31 (7):923-929.